BioCentury
ARTICLE | Company News

Cancer Research UK, Monopar Therapeutics deal

August 10, 2015 7:00 AM UTC

Cancer Research UK will fund and complete preclinical development of Monopar’s HuATN-658 and conduct a Phase I trial of the product in cancer patients. Upon completion of the Phase I trial, Monopar wi...